產(chǎn)品詳情
簡單介紹：
Anti-BCAR1抗體產(chǎn)品質量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-BCAR1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-BCAR1
Cat. Number:
Anti-BCAR1抗體KL-6223R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
p130 represents one ofAnti-BCAR1抗體 several known substrates for v-Crk encoded p47. p130 Cas (for Crk-associated substrate) exhibits a high level of tyrosine phosphorylation and is tightly associated with v-Crk, suggesting a role in v-Crk-mediated cell signaling. The molecular cloning of p130 Cas has shown it to represent a novel SH3 containing signaling molecule with a cluster of multiple putative SH2-binding motifs for v-Crk. By immunoprecipitation analysis, p130 Cas has been shown to be highly phosphorylated at tyrosine residues subsequent to either v-Src p60 or v-Crk-mediated transformation and to form stable complexes with both of these transforming proteins. p130 Cas behaves as an Anti-BCAR1抗體extremely potent substrate for protein tyrosine kinases and has been reported to relocate from the cytoplasm to cell membrane upon tyrosine phosphorylation. One proposed model is that the SH2 domain of v-Crk functions to activate c-Src kinase, which in turn phosphorylates p130 Cas.
Also known as:
Breast cancer anti Anti-BCAR1抗體estrogen resistance 1 protein; BCAR 1; Bcar1; BCAR1_HUMAN; Breast cancer anti estrogen resistance 1; Breast cancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein family member 1; Crk associated substrate; Crk associated substrate p130Cas; CRK-associated substrate; CRKAS; P130CAS.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human BCAR1.
●
Predicted Molecular Weight: 93kDa.
Storage:
Shipped at 4℃, Anti-BCAR1抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl867Mu01 脂蛋白關聯(lián)磷脂酶A2(LpPLA2)多克隆抗體 Polyclonal Antibody to Phospholikle A2, Lipoprotein Associated (LpPLA2)
kl867Ra01 脂蛋白關聯(lián)磷脂酶A2(LpPLA2)多克隆抗體 Polyclonal Antibody to Phospholikle A2, Lipoprotein Associated (LpPLA2)
kl868Hu01 內皮型一氧化氮合酶(NOS3)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Mu01 內皮型一氧化氮合酶(NOS3)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Po01 內皮型一氧化氮合酶(NOS3)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Ra01 內皮型一氧化氮合酶(NOS3)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl868Rb51 內皮型一氧化氮合酶(NOS3)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 3, Endothelial (NOS3)
kl871Ga01 熱休克蛋白β2(HSPβ2)多克隆抗體 Polyclonal Antibody to Heat Shock Protein Beta 2 (HSPb2)
kl871Hu01 熱休克蛋白β2(HSPβ2)多克隆抗體 Polyclonal Antibody to Heat Shock Protein Beta 2 (HSPb2)
kl871Ra01 熱休克蛋白β2(HSPβ2)多克隆抗體 Polyclonal Antibody to Heat Shock Protein Beta 2 (HSPb2)
